Naperville, IL -- (SBWIRE) -- 06/25/2014 -- Reportstack, provider of premium market research reports announces the addition of Global Molecular Cytogenetics Market 2014-2018 market report to its offering About Molecular Cytogenetics.
Molecular Cytogenetics involves the study of chromosomes using molecular biology to understand the role and functions of genes and chromosomes. It plays a crucial role in the early diagnosis of a disease, identification of genetic tendency to cause disease, and prediction of an individual's reaction to drugs. The FISH and aCGH play a prominent role in molecular cytogenetics technology. It involves the screening and diagnostic tests that are used for determining the complex interaction of genes and chromosomes to assess the status of a disease. In addition, molecular cytogenetics is mainly used in the R&D activities of research laboratories for drug discovery, identification of biomarkers, and screening drug candidates that react to these biomarkers.
Analysts forecast the Global Molecular Cytogenetics Market will grow at a CAGR of 23.51 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Molecular Cytogenetics market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of products used in molecular cytogenetics. The products employed in the use of FISH and aCGH techniques are considered within the scope of the report.
Global Molecular Cytogenetics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions with individual country-wise revenue segmentation; it also covers the Global Molecular Cytogenetics market landscape and its growth prospects in the coming years. The report also includes a share of the key vendors operating in this market.
Key Regions
Americas
EMEA
APAC
Key Vendors
Abbott Laboratories
Affymetrix Inc.
Agilent Technologies Inc.
F. Hoffmann-La Roche Ltd
Illumina Inc.
PerkinElmer Inc.
Other Prominent Vendors
Applied Spectral Imaging Ltd
Biological Industries Ltd
Bio-Rad Laboratories Inc.
Cytognomix Inc.
CytoTest Inc.
Illumina Inc.
Kreatech Inc.
Leica Biosystems Ltd
Life Technologies Corp.
Oxford Gene Technology Ltd
SciGene Corp.
Key Market Driver
Increasing Incidence of Genetic Disorders.
For a full, detailed list, view our report.
Key Market Challenge
Ethical and Social Constraints.
For a full, detailed list, view our report.
Key Market Trend
Increased Preference of Personalized Medicine.
For a full, detailed list, view our report.
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
Companies Mentioned
Abbott Laboratories , Affymetrix Inc. , Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, Illumina Inc., PerkinElmer Inc., Applied Spectral Imaging Ltd, Biological Industries Ltd, Bio-Rad Laboratories Inc., Cytognomix Inc., CytoTest Inc., Illumina Inc., Kreatech Inc. , Leica Biosystems Ltd, Life Technologies Corp., Oxford Gene Technology Ltd, SciGene Corp.
To view the table of contents for this market research report please visit
http://www.reportstack.com/product/158451/global-molecular-cytogenetics-market-2014-2018.html
Contact:
Roger Campbell
contactus@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604